home / stock / aim / aim articles

AIM Articles, AIM ImmunoTech Inc. - From 03/25/24

Stock Information
Company Name: AIM ImmunoTech Inc.
Stock Symbol: AIM
Market: NYSE
Website: aimimmuno.com
Menu
AIM AIM Quote AIM Short AIM News AIM Articles AIM Message Board
Get AIM Alerts

News, Short Squeeze, Breakout and More Instantly...
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying | Benzinga

The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern arou...
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity | Benzinga

OCALA, Fla., March 15, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), today announced that it will present a...

Kellner Seeking Expedited Appeal of Delaware Court Finding that Nomination Notice was Properly Denied | Benzinga

Court Found that Several AIM Advance Notice Bylaws Are Invalid NEW YORK, Jan. 3, 2024 /PRNewswire/ -- Ted D. Kellner, Todd Deutsch and Robert L. C...

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying | Benzinga

The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the ...
AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents | Benzinga

Extends certain exclusive U.S. rights to Ampligen for cancer and ME/CFS through 2039 Management discusses patent issuance and what this means in a...

Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card Now for Desperately Needed Change | Benzinga

Entrenched AIM Board Escalates Unconscionable Waste of Corporate Assets and Hostility to Stockholders Stockholders Urged to Act Now Before the Boa...

AIM ImmunoTech to Discuss Third Quarter 2023 Financial Results on November 15, 2023 and Host Conference Call and Webcast | Benzinga

OCALA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), announced today that management will ho...
AIM ImmunoTech Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting | Benzinga

OCALA, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM"), an immuno-pharma company focused on the research and dev...

AIM ImmunoTech Engages Business Development Firm, Azenova, LLC to Catalyze Partnering, Development and Commercialization Efforts for Ampligen® Pipeline Programs | Benzinga

OCALA, Fla., Oct. 17, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM") today announced it has entered into an agreement with Azen...

NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying | Benzinga

The Dow Jones closed lower by more than 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern aroun...
Previous 10 Next 10